Volume 4, Issue 2 (Avicenna Journal of Pharmaceutical Research, Dec 2024)                   Avicenna J Pharma Res 2024, 4(2): 74-86 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

D. Adedayo L, G. Aitokhuehi N, M. Ajayi A, Bamidele O, O. Adekeye A, A. Onasanwo S. Buchholzia coriacea Seed Methanol Extract Represses Nociception via Central Pathway Mechanisms in Swiss Mice. Avicenna J Pharma Res 2024; 4 (2) :74-86
URL: http://ajpr1.umsha.ac.ir/article-1-38-en.html
1- Neurophysiology Research Group, Physiology Programme, Bowen University, Iwo, Nigeria & Neurosciences Unit, Physiology Department, University of Ibadan, Nigeria
2- Neurosciences Unit, Physiology Department, University of Ibadan, Nigeria
3- Pharmacology and Therapeutics Department, University of Ibadan, Nigeria
4- Neurophysiology Research Group, Physiology Programme, Bowen University, Iwo, Nigeria
5- Department of Anatomy, Afe Babalola University, Ado-Ekiti, Nigeria
Abstract:   (95 Views)

Background: Nociception is a common feature of neurological disorders. Certain edible seeds contain bioactive phytochemicals with anti-nociceptive features. Buchholzia coriacea seed is traditionally used in folkloric medicine to manage pain-associated ailments. Hence, this study was conducted to assess the therapeutic properties of THE methanol extract of B. coriacea (MEBC) on nociception and its underlying mechanisms in Swiss mice.

Methods: B. coriacea seeds were purchased from the indigenous market in Oje, Ibadan, and authenticated at the Forest Herbarium Ibadan (FHI: 110572). The seeds were pulverized and cold-extracted with methanol. Forty-five male Swiss mice (23-27 g) were divided into nine treatment groups (n=5): control (10 mL/kg), MEBC (50, 100, 200 mg/kg, p.o.), and indomethacin (10 mg/kg, p.o.). Anti-nociceptive activity was evaluated one hour post-administration using the acetic acid-induced writhing test (AAWT), formalin-induced paw licking test (FPLT), and tail flick test (TFT).

Results: The gas chromatography–mass spectrometry (GC-MS) analysis revealed 31 compounds, with linoleic acid being the most abundant. In the mechanistic study, mice were pre-treated with naloxone (1 mg/kg), atropine (2 mg/kg), propranolol (10 mg/kg), or haloperidol (1.5 mg/kg), 15 minutes before MEBC (200 mg/kg) administration. MEBC (50, 100, 200 mg/kg) significantly reduced writhing in the AAWT, inflammatory pain in the FPLT, and increased latency in the TFT. The opiate blocker naloxone (1 mg/kg), cholinergic antagonist atropine (2 mg/kg), beta-adrenergic blocker propranolol (10 mg/kg), and dopamine D2 receptor antagonist haloperidol (1.5 mg/kg) were administered and significantly reversed the anti-nociception effect of MEBC when compared with the 200 mg/kg treatment in the TFT model.

Conclusion: The findings from this study demonstrate that B. coriacea inhibits nociception, which is attributed to the synergistic activity of its bioactive compounds as indicated by the GS-MC. The mechanisms of action are mediate via central nervous system pathways.

Full-Text [PDF 1726 kb]   (81 Downloads)    
Type of Study: Research | Subject: General
Received: 2026/09/28 | Accepted: 2024/02/29 | Published: 2026/09/28

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Avicenna Journal of Pharmaceutical Research

Designed & Developed by : Yektaweb